A large international study has recently shown that, independently of the receptor status and especially for BRCA1 pathogenic variants carriers, pregnancy after BC seems to be safe without negative consequences on maternal prognosis or fetal outcomes [19]. This evidence concerns the gene BRCA1 and breast cancer.